COPENHAGEN, April 26 (Reuters) - The world's No.1 insulin maker Novo Nordisk is expected to deliver more solid results on Tuesday with investors watching closely for comments on new blockbuster hope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results